01
International patent filing
Lynch LLP filed a PCT application for the client's biotech formulation, enabling protection across multiple jurisdictions. Strategic amendments and Chapter II filings ensured broad claim coverage and alignment with global patent offices.
02
National phase strategy
Recognizing the client's emerging international portfolio needs, we engaged early to develop a tailored national phase strategy — evaluating key markets, analyzing local patent frameworks, and identifying jurisdictions where alternative IP structures (such as utility models) may offer strategic advantages.
03
Continuation-in-Part planning
As the client continued to innovate in formulation and delivery methods, we guided the planning of CIPs to protect new embodiments while preserving priority dates — supporting long-term portfolio growth and technical flexibility.